Graphene-Based Smart Platforms for Combined Cancer Therapy

Area of Science:

• Nanomedicine
• Biomedical Engineering
• Materials Science

Background:

• Graphene and its derivatives are significant in nanomedicine.
• Applications extend from drug delivery to multiple therapeutic modalities.
• Graphene-based materials are increasingly used in combined therapies for enhanced anticancer effects.

Purpose of the Study:

• To review recent advances in smart graphene platforms for combined therapy applications.
• To outline the design principles of graphene-based smart platforms.
• To discuss current challenges and future prospects in this field.

Main Methods:

• Review of recent literature on graphene-based smart platforms.
• Analysis of combined therapeutic modalities including chemotherapy, photothermal therapy, and ultrasound therapy.
• Discussion of stimuli-responsive mechanisms (endogenous and exogenous).

Main Results:

• Graphene platforms serve as versatile carriers for combined therapies.
• Smart graphene nanocarriers can be activated by tumor microenvironment (pH, glutathione) or external stimuli (light, magnetic, ultrasound).
• Combined therapies show enhanced anticancer activity and reduced side effects compared to monotherapy.

Conclusions:

• Smart graphene platforms represent a promising approach for advanced cancer therapy.
• Stimuli-responsive nanocarriers offer targeted and efficient therapeutic strategies.
• Further research is needed to address challenges and realize the full potential of these materials.